1-2 of 2
Anne Marie Asemissen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1

Anne Marie Asemissen, Ulrich Keilholz, Stefan Tenzer, Margret Müller, Steffen Walter, Stefan Stevanovic, Hansjörg Schild, Anne Letsch, Eckhard Thiel, Hans-Georg Rammensee, Carmen Scheibenbogen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7476–7482.
https://doi.org/10.1158/1078-0432.CCR-06-1337
Published: 22 December 2006
View article titled, Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1
Open the PDF for Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1 in another window
Journal Articles

Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma In vivo: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104)

Anne Marie Asemissen, Carmen Scheibenbogen, Anne Letsch, Kristoffer Hellstrand, Fredrik Thorén, Kurt Gehlsen, Alexander Schmittel, Eckhard Thiel, Ulrich Keilholz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 290–297.
https://doi.org/10.1158/1078-0432.290.11.1
Published: 21 January 2005
View article titled, Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma <em>In vivo</em>: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104)
Open the PDF for Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma <em>In vivo</em>: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104) in another window